A warning letter sent to a Connecticut wholesaler about the sale of pure powdered caffeine points to the difficulty of keeping problematic products off the market in an environment in which hundreds of thousands of tons of cargo arrives in domestic ports...
With its first purchase order from Nestlé-owned Garden of Life in hand, Norwegian biotech company Hofseth BioCare (HBC) is gearing up for significant growth in North America with new products, exciting science, and unique claims.
Texas delivery technology development firm Santé Laboratories is opening up its cannabinoid delivery system to brand holders. The approach has been validated with a direct to consumer control brand called RESET Bioscience.
Pharmavite, the company behind the Nature Made brand of dietary supplements, is offering potential investment and/or partnerships for companies offering mental wellness solutions and supplement alternatives to OTC.
Swedish probiotic firm Probi is expanding its presence in APAC via a new deal with China National Pharmaceutical Foreign Trade Corporation (Sinopharm Foreign Trade).
Nutrition 21 started developing its award-winning NooLVL ingredient before Esports became such a thriving category. But the ingredient’s particular cognitive-support benefits have helped it catch a wave that has grown bigger through the pandemic’s influence.
DSM has today (31 March) agreed to acquire the flavour and fragrance (F&F) business of US-based biotech firm Amyris, extending its portfolio with bio-based ingredients for the flavor and fragrance and cosmetics industries.
Backed by new data, Bioenergy Life Sciences says its RiaGev ingredient is poised to make waves in the healthy energy category by bolstering cellular energy pathways and helping to arrest the cellular senescence process.
Careful supply chain management has helped high quality companies differentiate themselves during the unprecedented recent history of the dietary supplement sector, said one of the industry’s leading lights.
Nutrasource, a Canada-based contract research organization, quickly adapted to the pandemic by implementing regulations and best practices to continue running human trials. The company’s president and CEO, Will Rowe, and Josh Baisley, VP of clinical...
A new player is on the verge of entering the astaxanthin and other markets with the granting of a patent on a ‘dark fermentation’ process for cultivating Haematococcus pluvialis and other algae species.
